Are you a new member? Sign up now
Login area
| Sign up
close
OMNITROPE - 5mg/1.5ml - 5 x 1.5ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H01AC01 | BioTech | Somatropin recombinant - 5mg/1.5ml | 5185 | 222232/07 | OMNITROPE | 5mg/1.5ml | 5 x 1.5ml | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Sandoz GmbH | Austria | 26,295,485 L.L | 19.35 | D | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H01AC01 | BioTech | Somatropin recombinant - 5mg/1.5ml | 11244 | 59020/1 | CINNATROPIN | 5mg/1.5ml | 1 | Injectable solution | SC | Lebiran SARL | Cinnagen Co | Iran | 4,699,417 L.L | 23.08 | B | Cinnagen Co | Iran | 2/5/2024 | 0 |
| H01AC01 | BioTech | Somatropin recombinant - 5.3mg/1.15ml | 9395 | 154016/1 | GENOTROPIN | 5.3mg/1.15ml | 1 x 1.15ml | Injectable powder for solution+diluent | SC | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV PUURS | Belgium | 4,724,854 L.L | 21.26 | C | Pfizer SA | Belgium | 2/5/2024 | 0 |
| H01AC01 | BioTech | Somatropin recombinant - 16IU (5.32mg) | 10863 | 29618/1 | HHT | 16IU (5.32mg) | 1 | Injectable freeze dried powder + diluent | IM/SC | Droguerie Phenicia | BioSidus SAU | Argentine | 4,078,562 L.L | 23.08 | B | BioSidus SAU | Argentine | 2/5/2024 | 0 |
| H01AC01 | BioTech | Somatropin recombinant - 5mg/1.5ml | 2014 | 208835/03 | NORDITROPIN NORDIFLEX | 5mg/1.5ml | 1.5ml | Injectable solution | SC | Mersaco | Novo Nordisk AS | Denmark | 7,582,922 L.L | 21.26 | C | Novo Nordisk AS | Denmark | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024